مورد إلكتروني

Blood Biomarkers from Research Use to Clinical Practice: What Must Be Done? A Report from the EU/US CTAD Task Force.

التفاصيل البيبلوغرافية
العنوان: Blood Biomarkers from Research Use to Clinical Practice: What Must Be Done? A Report from the EU/US CTAD Task Force.
المؤلفون: Angioni, D, Angioni, D, Delrieu, J, Hansson, O, Fillit, H, Aisen, P, Cummings, J, Sims, JR, Braunstein, JB, Sabbagh, M, Bittner, T, Pontecorvo, M, Bozeat, S, Dage, JL, Largent, E, Mattke, S, Correa, O, Gutierrez Robledo, LM, Baldivieso, V, Willis, DR, Atri, A, Bateman, RJ, Ousset, P-J, Vellas, B, Weiner, M
المصدر: The journal of prevention of Alzheimer's disease; vol 9, iss 4, 569-579; 2274-5807
بيانات النشر: eScholarship, University of California 2022-01-01
نوع الوثيقة: Electronic Resource
مستخلص: Timely and accurate diagnosis of Alzheimer's disease (AD) in clinical practice remains challenging. PET and CSF biomarkers are the most widely used biomarkers to aid diagnosis in clinical research but present limitations for clinical practice (i.e., cost, accessibility). Emerging blood-based markers have the potential to be accurate, cost-effective, and easily accessible for widespread clinical use, and could facilitate timely diagnosis. The EU/US CTAD Task Force met in May 2022 in a virtual meeting to discuss pathways to implementation of blood-based markers in clinical practice. Specifically, the CTAD Task Force assessed: the state-of-art for blood-based markers, the current use of blood-based markers in clinical trials, the potential use of blood-based markers in clinical practice, the current challenges with blood-based markers, and the next steps needed for broader adoption in clinical practice.
مصطلحات الفهرس: Humans, Alzheimer Disease, Advisory Committees, Biomarkers, Alzheimer’s disease, amyloid, blood biomarkers, clinical trials, diagnostic, neurofilament light, p-tau, Prevention, Clinical Research, Aging, 4.1 Discovery and preclinical testing of markers and technologies, Detection, screening and diagnosis, Good Health and Well Being, article
URL: https://escholarship.org/uc/item/5fj72076
https://escholarship.org/
الإتاحة: Open access content. Open access content
public
ملاحظة: application/pdf
The journal of prevention of Alzheimer's disease vol 9, iss 4, 569-579 2274-5807
أرقام أخرى: CDLER oai:escholarship.org:ark:/13030/qt5fj72076
qt5fj72076
https://escholarship.org/uc/item/5fj72076
https://escholarship.org/
1391577147
المصدر المساهم: UC MASS DIGITIZATION
From OAIster®, provided by the OCLC Cooperative.
رقم الأكسشن: edsoai.on1391577147
قاعدة البيانات: OAIster